Sysmex ADR EBIT 2016-2024 | SSMXY

Sysmex ADR EBIT for the quarter ending December 31, 2024 was $0M, a 100% decline year-over-year.

  • Sysmex ADR 2025 EBIT was 0.578B, a 11.36% increase from 2024.
  • Sysmex ADR 2024 EBIT was 0.519B, a 4.79% decline from 2023.
  • Sysmex ADR 2023 EBIT was 0.545B, a 9.13% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

Sysmex ADR EBIT 2016-2024 | SSMXY

  • Sysmex ADR 2025 EBIT was 0.578B, a 11.36% increase from 2024.
  • Sysmex ADR 2024 EBIT was 0.519B, a 4.79% decline from 2023.
  • Sysmex ADR 2023 EBIT was 0.545B, a 9.13% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$183.5B
Thermo Fisher Scientific (TMO)$164.2B
Edwards Lifesciences (EW)$45.8B
Alcon (ALC)$43.1B
IDEXX Laboratories (IDXX)$42.9B
DexCom (DXCM)$32.7B
IQVIA Holdings (IQV)$28.2B
Mettler-Toledo (MTD)$25.4B
STERIS (STE)$22.4B
Waters (WAT)$21B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.6B
Penumbra (PEN)$9.2B
Masimo (MASI)$8.8B
Globus Medical (GMED)$7.7B
Glaukos (GKOS)$5.9B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$4.2B
TransMedics (TMDX)$3.8B
PROCEPT BioRobotics (PRCT)$3.1B
LivaNova (LIVN)$2.4B
Veracyte (VCYT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1B